Market Cap ₹115 Cr.
Stock P/E 0.0
P/B 2.4
Current Price ₹4.6
Book Value ₹ 1.9
Face Value 1
52W High ₹0
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3 | 6 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 1 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 3 | 7 | 3 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 2 | |
Total Expenditure | 0 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | |
Operating Profit | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Tax | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | |
Adjusted Earnings Per Share | 1.5 | 0.1 | 0.1 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0.1 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -67% | -31% | -24% | -10% |
Operating Profit CAGR | -67% | -31% | -20% | -10% |
PAT CAGR | -100% | -100% | -100% | -100% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 0% | -5% | -11% | -16% |
ROE Average | 0% | 2% | 3% | 8% |
ROCE Average | 1% | 3% | 3% | 7% |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 9 | 25 | 27 | 38 | 40 | 41 | 42 | 44 | 45 | 47 | 47 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 0 | 1 |
Total Current Liabilities | 3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 2 |
Total Liabilities | 12 | 26 | 30 | 42 | 43 | 43 | 45 | 48 | 49 | 49 | 50 |
Fixed Assets | 6 | 12 | 12 | 17 | 18 | 17 | 16 | 15 | 14 | 13 | 12 |
Other Non-Current Assets | 0 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 5 | 11 | 14 | 23 | 24 | 25 | 29 | 32 | 34 | 35 | 36 |
Total Assets | 12 | 26 | 30 | 42 | 43 | 43 | 45 | 48 | 49 | 49 | 50 |
#(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 1 | 5 | 5 | 1 | 2 | 2 | 3 | 4 | 2 | 2 | 1 |
Cash Flow from Investing Activities | -1 | -17 | -6 | -11 | -2 | -1 | -5 | -4 | -2 | -1 | -1 |
Cash Flow from Financing Activities | -0 | 12 | 1 | 10 | 0 | -1 | 1 | 0 | -0 | -1 | 0 |
Net Cash Inflow / Outflow | -0 | -1 | 0 | 1 | 0 | -0 | -1 | -0 | -0 | 0 | 0 |
Closing Cash & Cash Equivalent | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.5 | 0.1 | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.05 | 0.08 | 0.01 |
CEPS(Rs) | 1.5 | 0.13 | 0.1 | 0.12 | 0.13 | 0.11 | 0.11 | 0.11 | 0.09 | 0.1 | 0.03 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 4.35 | 1.03 | 1.1 | 1.53 | 1.58 | 1.63 | 1.69 | 1.77 | 1.82 | 1.89 | 1.9 |
Core EBITDA Margin(%) | 96.74 | 46.86 | 73.44 | 81.47 | 85.59 | 73.23 | 76.26 | 77.92 | 81.74 | 87.23 | 46.36 |
EBIT Margin(%) | 96.74 | 40.02 | 58.6 | 38.2 | 36.88 | 36.8 | 45.81 | 54.94 | 47.53 | 69.67 | 25.12 |
Pre Tax Margin(%) | 96.73 | 40.01 | 58.59 | 38.19 | 36.86 | 36.72 | 45.79 | 54.92 | 47.51 | 69.66 | 25.08 |
PAT Margin (%) | 96.73 | 39.65 | 57.51 | 36.16 | 33.96 | 35.03 | 44.14 | 53.25 | 46.21 | 68.47 | 18.22 |
Cash Profit Margin (%) | 96.73 | 47.67 | 75.84 | 85.99 | 92.06 | 76.91 | 81.27 | 82.72 | 84.08 | 91.65 | 65.85 |
ROA(%) | 27.93 | 13.41 | 6.57 | 3.43 | 2.84 | 2.85 | 3.23 | 3.89 | 2.44 | 3.9 | 0.44 |
ROE(%) | 43.42 | 15.1 | 7.06 | 3.79 | 3.14 | 3.09 | 3.46 | 4.2 | 2.63 | 4.13 | 0.46 |
ROCE(%) | 27.94 | 13.64 | 7.05 | 3.96 | 3.38 | 3.21 | 3.56 | 4.3 | 2.68 | 4.17 | 0.63 |
Receivable days | 110.26 | 117.7 | 158.02 | 128.4 | 239.27 | 299.67 | 338.58 | 279.29 | 341.34 | 318.38 | 752.52 |
Inventory Days | 352.7 | 99.34 | 30.68 | 27.67 | 48.56 | 60.09 | 59.33 | 40.01 | 32.85 | 38.54 | 88.26 |
Payable days | 0 | 0 | 0 | -420.71 | -326.27 | 2289.09 | 1135.41 | 333.51 | 1672.77 | -346.87 | 228.59 |
PER(x) | 0 | 30.38 | 443.27 | 465.59 | 954.38 | 699.6 | 330.73 | 128.16 | 114.62 | 0 | 564.37 |
Price/Book(x) | 0 | 3.07 | 30.36 | 15.06 | 29.46 | 21.23 | 11.25 | 5.28 | 2.98 | 0 | 2.58 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.98 | 12.15 | 254.8 | 168.11 | 323.82 | 244.6 | 146.03 | 68.4 | 53.11 | 8.99 | 102.68 |
EV/Core EBITDA(x) | 1.02 | 25.29 | 331.24 | 190.98 | 340.95 | 310.88 | 176.06 | 81.03 | 62.19 | 9.68 | 141.14 |
Net Sales Growth(%) | 75.79 | 111.46 | -50.31 | 6.22 | 5.13 | -1.33 | -7.9 | 4.7 | -25.23 | 9.47 | -57.23 |
EBIT Growth(%) | 37.4 | -12.52 | -27.24 | -30.76 | 1.49 | -1.54 | 14.64 | 25.57 | -35.32 | 60.48 | -84.58 |
PAT Growth(%) | 37.4 | -13.32 | -27.92 | -33.21 | -1.27 | 1.77 | 16.04 | 26.3 | -35.12 | 62.22 | -88.62 |
EPS Growth(%) | -77.1 | -93.03 | -27.96 | -34.22 | -1.27 | 1.69 | 16.13 | 26.39 | -35.16 | 62.29 | -88.64 |
Debt/Equity(x) | 0.38 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Current Ratio(x) | 1.66 | 14.09 | 17.01 | 17.28 | 15.91 | 15.97 | 19.11 | 19.45 | 18.44 | 27.62 | 22.33 |
Quick Ratio(x) | 0.69 | 13.61 | 16.81 | 17.01 | 15.51 | 15.61 | 18.78 | 19.3 | 18.33 | 27.32 | 22.21 |
Interest Cover(x) | 0 | 8521.3 | 8164.11 | 4212.14 | 2596.66 | 446 | 3131.04 | 2443.31 | 2543.1 | 5935.42 | 595.71 |
Total Debt/Mcap(x) | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 | 79.42 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 | 19.75 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 | 24.86 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About